News Azithromycin for mild-to-moderate COVID-19 Azithromycin has been widely evaluated for its efficacy against COVID-19.
News Biogen claims first with FDA nod for biosimilar Actemra Biogen says it is the first drugmaker in the US to get FDA approval for a biosimilar of Roche’s $3 billion blockbuster product Actemra.
R&D Turning drug development on its head Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho
